BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 27208546)

  • 1. Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?
    Winter A; Sirri E; Jansen L; Wawroschek F; Kieschke J; Castro FA; Krilaviciute A; Holleczek B; Emrich K; Waldmann A; Brenner H;
    BJU Int; 2017 Apr; 119(4):550-559. PubMed ID: 27208546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.
    Collin SM; Martin RM; Metcalfe C; Gunnell D; Albertsen PC; Neal D; Hamdy F; Stephens P; Lane JA; Moore R; Donovan J
    Lancet Oncol; 2008 May; 9(5):445-52. PubMed ID: 18424233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States.
    Sirri E; Castro FA; Kieschke J; Jansen L; Emrich K; Gondos A; Holleczek B; Katalinic A; Urbschat I; Vohmann C; Brenner H
    Pancreas; 2016 Jul; 45(6):908-14. PubMed ID: 26745860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics.
    Negoita S; Feuer EJ; Mariotto A; Cronin KA; Petkov VI; Hussey SK; Benard V; Henley SJ; Anderson RN; Fedewa S; Sherman RL; Kohler BA; Dearmon BJ; Lake AJ; Ma J; Richardson LC; Jemal A; Penberthy L
    Cancer; 2018 Jul; 124(13):2801-2814. PubMed ID: 29786851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study.
    Hager B; Kraywinkel K; Keck B; Katalinic A; Meyer M; Zeissig SR; Scheufele R; Wirth MP; Huber J
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):61-66. PubMed ID: 27618951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
    Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
    Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Prostate Cancer Incidence Rates and Prevalence of Prostate Specific Antigen Screening by Socioeconomic Status and Regions in the United States, 2004 to 2013.
    Houston KA; King J; Li J; Jemal A
    J Urol; 2018 Mar; 199(3):676-682. PubMed ID: 28965781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century.
    Pulte D; Castro FA; Jansen L; Luttmann S; Holleczek B; Nennecke A; Ressing M; Katalinic A; Brenner H;
    J Hematol Oncol; 2016 Mar; 9():28. PubMed ID: 27000264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.
    Brenner H; Arndt V
    J Clin Oncol; 2005 Jan; 23(3):441-7. PubMed ID: 15572727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
    Etzioni R; Penson DF; Legler JM; di Tommaso D; Boer R; Gann PH; Feuer EJ
    J Natl Cancer Inst; 2002 Jul; 94(13):981-90. PubMed ID: 12096083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis.
    Gondos A; Arndt V; Holleczek B; Stegmaier C; Ziegler H; Brenner H
    Int J Cancer; 2007 Jul; 121(2):395-400. PubMed ID: 17372898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?
    Valberg M; Grotmol T; Tretli S; Veierød MB; Moger TA; Devesa SS; Aalen OO
    Eur J Epidemiol; 2017 Jun; 32(6):511-520. PubMed ID: 27431530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
    Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS
    J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database.
    Bandini M; Mazzone E; Preisser F; Nazzani S; Zaffuto E; Marchioni M; Tian Z; Pompe RS; Tilki D; Graefen M; Shariat SF; Montorsi F; Saad F; Briganti A; Karakiewicz P
    Eur Urol Oncol; 2018 Sep; 1(4):314-320. PubMed ID: 31100253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of prostate-cancer mortality: caution advised.
    Etzioni R; Feuer E
    Lancet Oncol; 2008 May; 9(5):407-9. PubMed ID: 18452850
    [No Abstract]   [Full Text] [Related]  

  • 18. Decrease in prostate cancer incidence and mortality in Germany - effects of opportunistic PSA screening or more?
    Rohde V; Weidner W; Katalinic A
    Urol Int; 2009; 83(2):134-40. PubMed ID: 19752605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence--data from the Utah Cancer Registry.
    Stephenson RA; Smart CR; Mineau GP; James BC; Janerich DT; Dibble RL
    Cancer; 1996 Apr; 77(7):1342-8. PubMed ID: 8608513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer in young men: An emerging young adult and older adolescent challenge.
    Bleyer A; Spreafico F; Barr R
    Cancer; 2020 Jan; 126(1):46-57. PubMed ID: 31553489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.